Before examining potential roles of VRAC in the cGAMP-mediated anti-tumor immune response, we used a cGAS-deficient MC38 cell line (Fig. S1A) to validate that tumor-produced cGAMP affects cancer growth in vivo. This evidence concerns the gene CGAS and neoplasm.